Whalegun
Home

Kyverna Therapeutics KYTX paid Brownstein Hyatt Farber Schreck $60K for lobbying in Q2 2026 · Pharmacy

Trade details

Type
Lobbying report
Amount
$60,000
Quarter
Q2 2026
Stock
Kyverna Therapeutics KYTX
Client
Kyverna Therapeutics
Reported
26/07/17

Up 200.0% from last quarter

What else happened in Kyverna Therapeutics around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Kyverna Therapeutics's other lobbying reports

  • Kyverna Therapeutics

    LobbyingKyverna Therapeutics

    $60K

    Reported 07/20

  • Kyverna Therapeutics

    LobbyingKyverna Therapeutics

    $60K

    Reported 04/20

  • Kyverna Therapeutics

    LobbyingKyverna Therapeutics

    $20K

    Reported 04/19

  • Kyverna Therapeutics

    LobbyingKyverna Therapeutics

    $50K

    Reported 01/20

Kyverna Therapeutics KYTX paid Brownstein Hyatt Farber Schreck $60K for lobbying in Q2 2026 · Pharmacy | Whalegun